Progress of ClarVista’s Harmoni Modular Intraocular Lens

Paul McLean, ClarVista Medical’s CEO, stressed the importance of rotational stability as he extolled the benefits of the company’s Harmoni Modular Intraocular Lens (IOL). The firm expects to file an IDE this year and begin its US clinical trial in 2018.